Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gailani

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Expert Review of Hematology|May 25, 2016
Why factor XI deficiency is a clinical concernAllison P Wheeler, David Gailani
Journal of Thrombosis and Haemostasis : JTH|August 19, 2023
Kininogen debuts on apple (domain) disksBassem M Mohammed, David Gailani
Drug Discovery Today|June 3, 2014
Factor XI as a target for antithrombotic therapyCharles E Bane, David Gailani
Clinics in Laboratory Medicine|May 15, 2026
Pharmacologic Factor XI/XIa Inhibitors: What the Laboratory Hematologist Needs to KnowJeffrey I Weitz, David Gailani
Current Opinion in Hematology|July 7, 2011
Factor XI and XII as antithrombotic targetsFelicitas Müller, David Gailani, Thomas Renné
Current Opinion in Hematology|June 13, 2017
Single-chain factor XII: a new form of activated factor XIIIvan Ivanov, Anton Matafonov, David Gailani
Journal of Thrombosis and Haemostasis : JTH|October 27, 2020
Proteolytic activity of contact factor zymogensAleksandr Shamanaev, Jonas Emsley, David Gailani
Blood Cells, Molecules & Diseases|February 10, 2006
The intrinsic pathway of coagulation is essential for thrombus stability in miceThomas Renné, Bernhard Nieswandt, David Gailani
Current Opinion in Hematology|August 2, 2022
Recent advances in factor XII structure and functionAleksandr Shamanaev, Maxim Litvak, David Gailani
Expert Review of Hematology|May 22, 2020
The clinical management of factor XI deficiency in pregnant womenAllison P Wheeler, Celeste Hemingway, David Gailani
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Expert Review of Hematology|May 25, 2016
Why factor XI deficiency is a clinical concernAllison P Wheeler, David Gailani
Journal of Thrombosis and Haemostasis : JTH|August 19, 2023
Kininogen debuts on apple (domain) disksBassem M Mohammed, David Gailani
Drug Discovery Today|June 3, 2014
Factor XI as a target for antithrombotic therapyCharles E Bane, David Gailani
Clinics in Laboratory Medicine|May 15, 2026
Pharmacologic Factor XI/XIa Inhibitors: What the Laboratory Hematologist Needs to KnowJeffrey I Weitz, David Gailani
Current Opinion in Hematology|July 7, 2011
Factor XI and XII as antithrombotic targetsFelicitas Müller, David Gailani, Thomas Renné
Current Opinion in Hematology|June 13, 2017
Single-chain factor XII: a new form of activated factor XIIIvan Ivanov, Anton Matafonov, David Gailani
Journal of Thrombosis and Haemostasis : JTH|October 27, 2020
Proteolytic activity of contact factor zymogensAleksandr Shamanaev, Jonas Emsley, David Gailani
Blood Cells, Molecules & Diseases|February 10, 2006
The intrinsic pathway of coagulation is essential for thrombus stability in miceThomas Renné, Bernhard Nieswandt, David Gailani
Current Opinion in Hematology|August 2, 2022
Recent advances in factor XII structure and functionAleksandr Shamanaev, Maxim Litvak, David Gailani
Expert Review of Hematology|May 22, 2020
The clinical management of factor XI deficiency in pregnant womenAllison P Wheeler, Celeste Hemingway, David Gailani
Pageof 17